(Q40965557)

25 September 2017

Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas (English)

1 reference

25 September 2017

Chaperot L

1

1 reference

25 September 2017

Plumas J

2

1 reference

25 September 2017

Jacob MC

3

1 reference

25 September 2017

Bost F

4

1 reference

25 September 2017

Molens JP

5

1 reference

25 September 2017

Sotto JJ

6

1 reference

25 September 2017

Bensa JC

7

1 reference

25 September 2017

1 March 1999

1 reference

25 September 2017

Experimental Hematology

1 reference

25 September 2017

27

1 reference

25 September 2017

479-488

1 reference

25 September 2017

3

1 reference

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2898%2900059-9

7 January 2021

Adhesion receptors of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2898%2900059-9

7 January 2021

The B7 and CD28 receptor families

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2898%2900059-9

7 January 2021

Do B cells drive the diversification of immune responses?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2898%2900059-9

7 January 2021

Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2898%2900059-9

7 January 2021

B70 antigen is a second ligand for CTLA-4 and CD28.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2898%2900059-9

7 January 2021

Malignant B lymphocytes from non-Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: an important role of co-stimulatory molecules CD80 (B7-1) and CD86 (B7-2) in stimulation by tumo

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2898%2900059-9

7 January 2021

Isolation of human T and B lymphocytes by rosette formation with 2-aminoethylisothiquronium bromide (AET) -treated sheep red blood cells with monkey red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2898%2900059-9

7 January 2021

Fas ligation induces apoptosis of CD40-activated human B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2898%2900059-9

7 January 2021

Long-Term Human B Cell Lines Dependent on Interleukin-4 and antibody to CD40

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2898%2900059-9

7 January 2021

Localization in situ of the co-stimulatory molecules B7.1, B7.2, CD40 and their ligands in normal human lymphoid tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2898%2900059-9

7 January 2021

Failure of B Cells of Chronic Lymphocytic Leukemia in Presenting Soluble and Alloantigens

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2898%2900059-9

7 January 2021

Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2898%2900059-9

7 January 2021

Functional CD40 on B lymphocytes and dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2898%2900059-9

7 January 2021

Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2898%2900059-9

7 January 2021

Autotumour reactive T-cell clones among tumour-infiltrating T lymphocytes in B-cell non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2898%2900059-9

7 January 2021

10.1016/S0301-472X(98)00059-9

Identifiers

DOI

1 reference

25 September 2017

1 reference